Fig. 1From: Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2−, node-positive early breast cancerDerivation of analysis dataset (n = 298). 1Includes 80 samples with RS 26–100. HER2−, human epidermal growth factor receptor 2-negative; HR+, hormone receptor-positive; n, sample size; N0, node-negative; N1, 1–3 positive lymph nodes; RS, Recurrence Score®Back to article page